MedPath

Acupuncture in Traumatic Brain Injury

Not Applicable
Completed
Conditions
Chronic Post-traumatic Headache
Mild Traumatic Brain Injury
Interventions
Procedure: Acupuncture
Registration Number
NCT04369911
Lead Sponsor
HealthPartners Institute
Brief Summary

The purpose of the study is to determine the effect of a low vs. high dose of acupuncture treatment in individuals with chronic post-traumatic headache (CPTH). A total of 36 people with mild traumatic brain injury (mTBI) suffering from CPTH will be enrolled in this study to receive acupuncture treatment for 5 weeks. Participants will be randomized into two groups: 1) Low Acupuncture group (5 treatments) and 2) High Acupuncture group (10 treatments). It is hypothesized that both treatment groups will have decreased headaches, but that 10 treatments will greater alleviate headaches when compared to 5 treatments.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Ability to provide and provision of signed and dated informed consent form
  • Age 18-65
  • Diagnosis of mild traumatic brain injury (mTBI) (as defined by the International classification of headache disorders 3rd edition (ICHD-3); a. Either no loss of consciousness, or loss of consciousness of <30 minutes duration, b. Glascow Coma Scale (GCS) ≥ 13, and c. Symptoms and/or signs diagnostic of concussion)
  • Diagnosis of mTBI ≥3 months and ≤12 months at the time of study enrollment
  • Suffering from chronic post-traumatic headache (CPTH) of any etiology (e.g. tension or migraine), with chronic defined as developed within 7 days after injury and lasting ≥3 months from the time of injury
  • Stable medication regimen for ≥1 months and agree to adhere to his or her current medication treatment regimen through study participation
Exclusion Criteria
  • Non-English speaking
  • History of acupuncture since diagnosis of mTBI
  • History of pre-existing primary headache, defined as more than 12 days of tension-type headache annually and/or more than one migraine attacks per month in the last year
  • History of any other serious neurological, psychiatric, chronic pain disorders, or seizures
  • History of bleeding diathesis, other bleeding disorders, or syncope with needle puncture
  • History of cardiac arrhythmia or current pacemaker, neurostimulator, or other implanted stimulation device
  • Recent or active substance use disorder
  • Women who are currently pregnant, lactating, or planning to become pregnant during the study
  • Any other medical conditions that could affect their ability to participate in acupuncture treatments for the study duration (as determined by study investigators)
  • Active participation or past participation ≤3 months in any other interventional study.
  • Unwilling to participate in all study related activities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low DoseAcupunctureAcupuncture treatment once per week for 5 weeks. Five total acupuncture treatments completed.
High DoseAcupunctureAcupuncture treatment twice per week for 5 weeks. Ten total acupuncture treatments completed.
Primary Outcome Measures
NameTimeMethod
Change in Number of Headache Daysbaseline to 3 months

The number of self-reported headache days over a 4 week period. Range: 0-28 days. More headache total days indicates a worse outcome.

Secondary Outcome Measures
NameTimeMethod
Adverse Events16 weeks

The total number of adverse events (AE) or serious adverse events (SAE) over the course of the study. A higher number of AE/SAEs indicates a less safe treatment.

Compliance With Overall Protocol3 months

Completion of treatment sessions. Percent of target treatments. Range: 0-100. A higher percentage indicates more compliance.

Trial Locations

Locations (1)

HealthPartners Neuroscience Center

🇺🇸

Saint Paul, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath